Worcester, MA, April 18, 2005 - Advanced Cell Technology, Inc. (OTC Bulletin Board: ACTH.OB), a leading biotechnology company applying stem cell technology in the emerging field of regenerative medicine, today announced that the Company has filed Form 8-K/A with the Securities and Exchange Commission (the "SEC�?). This document, required by the SEC, discloses the Company's financial statements for periods ending December 31, 2004.
"This is an important step for Advanced Cell Technology - our timely filing on Form 8K of financial statements required following our recent merger transaction,�? said James Stewart, Chief Financial Officer of Advanced Cell Technology. "ACT looks forward to providing full and complete disclosure to the investing public interested in this promising new industry.�?
About Advanced Cell Technology
A.C.T. Holdings, Inc., a Nevada corporation, and its wholly-owned subsidiary, Advanced Cell Technology, Inc., a Delaware corporation, is a biotechnology company applying stem cell technology in the emerging field of regenerative medicine. The company is currently headquartered in Worcester, Massachusetts.
For more information about Advanced Cell Technology visit "www.advancedcell.com":http://www.advancedcell.com
Forward-Looking Statements
This press release contains forward looking statements that involve risks and uncertainties. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties that may cause the company's actual results in future periods to differ materially from results expressed or implied by forward-looking statements. You should not place undue reliance on forward-looking statements because they involve these risks and uncertainties. You should independently investigate and fully understand all risks before making investment decisions.
A.C.T. Holdings, Inc.
Frequently Requested Info